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ABSTRACT
The Cfr methyltransferase confers combined resis-
tance to five classes of antibiotics that bind to the
peptidyl tranferase center of bacterial ribosomes by
catalyzing methylation of the C-8 position of 23S
rRNA nucleotide A2503. The same nucleotide is
targeted by the housekeeping methyltransferase
RlmN that methylates the C-2 position. Database
searches with the Cfr sequence have revealed
a large group of closely related sequences from all
domains of life that contain the conserved CX3CX2C
motif characteristic of radical S-adenosyl-L-
methionine (SAM) enzymes. Phylogenetic analysis
of the Cfr/RlmN family suggests that the RlmN sub-
family is likely the ancestral form, whereas the
Cfr subfamily arose via duplication and horizontal
gene transfer. A structural model of Cfr has been
calculated and used as a guide for alanine muta-
genesis studies that corroborate the model-based
predictions of a 4Fe–4S cluster, a SAM molecule
coordinated to the iron–sulfur cluster (SAM1) and a
SAM molecule that is the putative methyl group
donor (SAM2). All mutations at predicted functional
sites affect Cfr activity significantly as assayed by
antibiotic susceptibility testing and primer extension
analysis. The investigation has identified essential
amino acids and Cfr variants with altered reaction
mechanisms and represents a first step towards
understanding the structural basis of Cfr activity.
INTRODUCTION
The cfr gene was originally identiﬁed as a
chloramphenicol–ﬂorfenicol resistance determinant on a
multiresistance plasmid isolated during a surveillance
study of ﬂorfenicol resistance among staphylococci from
animals (1). It was subsequently shown to encode an
rRNA methyltransferase (MTase) that targets nucleotide
A2503 of Escherichia coli 23S rRNA (2). Antimicrobial
susceptibility testing of E. coli and Staphylococcus aureus
strains expressing the Cfr MTase revealed that these
strains exhibit combined resistance to a number of chem-
ically unrelated drugs that bind to overlapping sites
that abut nucleotide A2503 at the ribosomal peptidyl
transferase center (2,3). The phenotype was named
PhLOPSA for resistance to the following drug classes:
Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins,
and Streptogramin A antibiotics (3). It is also known that
Cfr expression confers resistance to the 16-membered
macrolides josamycin and spiramycin (4). Thus, the
Cfr-mediated resistance functions in both Gram-positive
and -negative bacteria and includes important
antimicrobial agents that are currently used in human
and/or veterinary medicine. The detection of cfr on
plasmids and transposons raises concerns about spreading
of Cfr-mediated resistance (5).
In a recent study, the speciﬁc identity of the Cfr-
mediated methylation at nucleotide A2503 of 23S rRNA
was determined to be 8-methyladenosine, a hitherto
undescribed modiﬁcation in natural RNA molecules (6).
It was also revealed that Cfr has a less pronounced ability
to catalyze methylation at position C-2 of A2503 to form
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by Cfr is provided by methylation at position C-8 and is
independent of methylation at position C-2 (6). In E. coli,
there is a natural m
2A methylation at A2503 (7) that is
mediated by the RlmN MTase (8). This methylation is
considered to be a housekeeping modiﬁcation rather
than a genuine antibiotic resistance determinant, as lack
of the methylation only causes a slight increase in suscep-
tibility to hygromycin A, linezolid, sparsomycin and
tiamulin (8).
The sequences of Cfr and RlmN are similar to
each other but show no signiﬁcant similarity to other
known enzymes involved in resistance against the above-
mentioned antibiotics or to any known MTases. However,
multiple sequence alignments of the Cfr/RlmN family
(1,8) have revealed a cysteine-rich motif similar to a
catalytic motif of radical-S-adenosyl-L-methionine
(SAM) enzymes (9,10). Radical-SAM enzymes contain a
[4Fe–4S]
+ cluster that is coordinated by the three
conserved cysteine thiolate side chains in the CX3CX2C
motif and one molecule of SAM (10). The reactions
catalyzed by radical-SAM enzymes are diverse, but their
mechanisms all involve the cleavage of unreactive C–H
bonds by a 50-deoxyadenosyl radical generated by
reductive cleavage of SAM (10). The mutation of single
conserved cysteines in the CX3CX2C motif of Cfr
abolishes its activity, lending support to the idea that the
Cfr modiﬁcation reaction occurs via a radical-based mech-
anism (6).
In this study, bioinformatics analysis of the Cfr/RlmN
family for the ﬁrst time establishes their signiﬁcant evolu-
tionary link with radical-SAM enzymes. Also, a structural
model of Cfr was built using theoretical protein structure
prediction methods to guide the investigation of sequence–
function relationships. Finally, mutagenesis of selected
single residues in Cfr and functional analysis of the
mutant proteins has identiﬁed essential amino acids and
supports the predictions of ligand binding sites.
MATERIALS AND METHODS
Sequence analysis
Searches of the current version of non-redundant sequence
database (nr) were carried out using a local version of
PSI-BLAST (11) with E-value threshold of 0.001, until
convergence. All sequences were extracted and a prelimi-
nary alignment was calculated using MUSCLE (12) with
default parameters and a preliminary tree was calculated
using the neighbor-joining approach implemented in
MEGA4 (13). Incomplete sequences and alternative
versions of the same protein from the same species were
removed. Finally, the multiple sequence alignment was
reﬁned manually to ensure that no unwarranted gaps
had been introduced within a-helices and b-strands.
A phylogenetic tree was calculated with MEGA4 (13)
using the minimum evolution (ME) method, with the
JTT model of substitutions and pairwise deletions, and
the initial tree calculated by the ME method with the
Closest Neighbor Search option set to level=2. The sta-
bility of individual nodes was calculated using the
bootstrap test (1000 replicates) to judge the strength
of statistical support for nodes on phylogenetic trees.
The number presented by each node reﬂects the percent-
age of bootstrap trees that resolve a given clade.
Additionally, the statistical support for each node was
conﬁrmed by the Interior Branch Test (ITB) in all trees
(1000 replicates). For all branches with bootstrap support
>50%, the ITB support was equal or higher (data not
shown).
Protein fold recognition: identiﬁcation of domains and
templates
Secondary structure prediction and tertiary fold-
recognition (FR) were carried out via the GeneSilico
MetaServer (14), (http://genesilico.pl/meta2/ for details).
Based on the coverage of the query sequence by potential
template domains detected by FR, two independently
folded domains in the query protein sequence were
identiﬁed, and the corresponding sequence fragments
(aa 1–102 and 103–312) and the remaining C-terminal
extension (aa 313–349) were submitted to the
MetaServer as additional independent queries. FR align-
ments between the query sequence and its fragments
were compared, evaluated, and ranked by the Pcons
method (15).
Protein structure modeling
Models of individual domains in the query sequence were
constructed based on the FR results using the so-called
‘FRankenstein’s Monster’ approach (16,17). The most
up-to-date version of this protocol involves iterative
model building by MODELLER (18), evaluation by
MetaMQAP (see below for a more detailed explanation),
realignment in poorly scored regions and merging of
best-scoring fragments. The conformations of the
N-terminus (aa 1–102) and the C-terminus (aa 313–349)
were modeled de novo with the ROSETTA method for
template-free modeling of protein structure (19), and the
resulting models were optimized with REFINER (20).
Protein model evaluation and structure analysis
The predicted accuracy of modeled structures (i.e. their
expected agreement with the true structures that are
unknown) was calculated with the model quality assess-
ment programs (MQAPs) MetaMQAP (21) and PROQ
(22). MQAPs work best with single domains and are
usually incapable of predicting the accuracy of mutual
positions of domains. MQAPs merely predict the devia-
tion of a model from the real structure, as a real deviation
can only be calculated if the real structure is known. Thus,
scores that indicate e.g. ‘very good models’, must be inter-
preted as estimations or predictions that our models are
‘very good’, and not as ultimate validation of the model
quality.
Models and their features were visualized with PyMOL
(23). Mapping of the electrostatic potential on protein
surfaces was done with Adaptive Poisson-Boltzmann
Solver (APBS) (24). Mapping of sequence conservation
on protein surfaces was done with COLORADO3D (25)
and CONSURF (26).
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Escherichia coli strains were grown in LB medium using
standard procedures (27) and in the presence of 100mg/ml
ampicillin where appropriate for plasmid selection
and maintenance. The hyperpermeable strain AS19 (28)
was transformed with plasmid-borne cfr genes (wt and
mutated genes) and used for antibiotic susceptibility
testing. The ‘Keio’ collection strain JW2501-1 (29),
where the rlmN (yfgB) gene is replaced with a kanamycin
resistance cassette, was also transformed with plasmid-
borne cfr genes (wt and mutated genes) and used for
isolation of RNA for primer extension analysis.
Cloning of cfr and construction of plasmids encoding
Cfr mutant proteins
The cfr gene was ampliﬁed by PCR using the upstream
primer 50-GCGCATTGCATATGCATCACCATCAC
CATCACAAAGAAATGAATTTTAATAATAAA-30
encoding a N-terminal histidine aﬃnity tag and the down-
stream primer 50-CATAGCAAGCTTCTATTGGCTATT
TTGATAATTAC-30. The plasmid pBglII (Cfr+) (2) con-
taining the cfr gene cloned into the pBluescript II SK+
vector (Stratagene) was used as a template in the PCR
ampliﬁcation. The tagged cfr gene was brought under
control of the lac promoter by insertion into the NdeI
and HindIII sites in plasmid pLJ102 (30) to form
plasmid pCfrHis. The pCfrHis plasmids encoding Cfr
mutants containing a single amino acid to alanine
mutation at residues R25, Q28, E91, C105, C110, C112,
C116, F118, C119, S189, S212, H214 and C338 were con-
structed in two steps using overlap extension PCR (27).
First, two overlapping fragments were ampliﬁed with an
outer primer complementary to sequences ﬂanking the 50
or 30 end of the cfr gene and a mutagenic primer in the
opposite orientation introducing the appropriate muta-
tions (Supplementary Table S1). The two outer primers
were then used to amplify fragments containing full-length
mutant cfr genes, with the two overlapping fragments
from the ﬁrst step used as the template (Supplementary
Table S1). The fragments were cloned into the NdeI and
HindIII sites of plasmid pLJ102 to form the pCfrHis
plasmids. The plasmids were sequenced to conﬁrm the
presence of the mutations and then used to transform E.
coli strains AS19 and JW2501-1.
Antibiotic susceptibility testing
Drug susceptibility testing was done in a microtiter plate
format by measuring optical density values at 450nm with
a microtiter plate reader (Victor 3, Perkin Elmer). LB
medium was inoculated with single colonies and incubated
overnight at 37 C. The cultures were diluted to
OD450=0.01 and 100ml diluted culture was mixed with
100ml of antibiotic solutions in water in a series with
2-fold concentration steps and all strains were induced
by addition of 1mM IPTG. The tested concentration
ranges were: ﬂorfenicol 0.25–32mg/ml and tiamulin
0.5–128mg/ml. The minimal inhibitory concentration
(MIC) was deﬁned as the lowest tested drug concentration
at which the growth of the cultures was completely
inhibited after 48h of incubation at 37 C. Although repro-
ducible 2-fold diﬀerences in MICs do not represent large
changes in antibiotic susceptibility, they can nevertheless
represent measurable small changes in activity.
Primer extension analysis
For RNA isolation, overnight cultures were diluted into
LB medium supplemented with 100mg/ml ampicillin and
incubated with shaking at 37 C. After 45min, the cultures
were induced with 1mM IPTG and incubated until OD450
reached 0.5. Total RNA was isolated with the RNeasy kit
(Qiagen). For isolation of ribosomal RNA, cells were har-
vested, washed with TMN buﬀer (50mM Tris–HCl at pH
7.8, 10mM MgCl2, 100mM NH4Cl) and resuspendedin
TMN. The cells were then lysed by sonication, followed by
removal of cell debris by centrifugation. The supernatants
were loaded on 10–40% sucrose gradientsin TMN and
subjected to ultracentrifugation in the swinging bucket
rotor AH629 (18000 r.p.m., 19h, 4 C). The 70S fractions
(and for Cfr mutant C105A also the 50S fractions) were
collected and dialysed against TMN. Finally, the 70S
ribosomes were pelleted by ultracentrifugation in a Ti 50
rotor (40000r.p.m., 24h, 4 C) and dissolved in TMN.
Following phenol extraction of 70S ribosomes, ribosomal
RNA was precipitated with ethanol, and resuspended in
water.
Modiﬁcation of ribosomal RNA was monitored by
primer extension analysis (31) with AMV reverse trans-
criptase (Finnzymes). The 50-[
32P]-labeled deoxyoligo-
nucleotide primer (50-GAACAGCCATACCCTTG-30),
complementary to nucleotides 2540–2556 of E. coli 23S
rRNA was used. The cDNA extension products were
separated on 6% polyacrylamide sequencing gels. The
positions of the stops were visualized by autoradiography
and identiﬁed by referencing to dideoxynucleotide
sequencing reactions on 23S rRNA that were electro-
phoresed in parallel.
RESULTS
Sequence analysis and phylogeny of the Cfr/RlmN family
To address the question of whether Cfr is a true member
of the radical-SAM superfamily, a comprehensive
bioinformatics analysis of Cfr, RlmN and other known
radical-SAM enzymes was carried out. Sequence
database searches with the Cfr sequence as a query
against the nr database led to the identiﬁcation of a
large family of 731 closely related sequences from all
three domains of life and from viruses. Figure 1 shows a
multiple sequence alignment of selected Cfr/RlmN
members and the complete alignment is available as
Supplementary Data. The conserved CX3CX2C motif is
present in all members with the sole exception of an
uncharacterized protein from Ureaplasma parvum
(GI 13357773) that is likely to be an enzymatically
inactive member of the Cfr/RlmN family.
In order to elucidate the phylogenetic relationships of
the Cfr/RlmN family we have calculated the Minimum
Evolution phylogenetic tree based on the complete
1654 Nucleic Acids Research, 2010,Vol.38, No. 5Figure 1. Multiple alignment of representative members of the Cfr/RlmN family. The sequences represent members of major phyla and have been
selected based on phylogenetic analysis. The sequences are named using six-letter abbreviations for genus and species, for instance: Esccol for
Escherichia coli, followed by the gene name and the NCBI gene identiﬁcation number. Residues that are conserved and physicochemically similar in
>50% of the sequences are indicated by black and grey shading, respectively. Secondary-structures predicted for Cfr and observed in the template
crystal structure (MoaA; PDB accession code 1tv8) are indicated as arrows (strands) and tubes (helices) at the bottom of the ﬁgure. Strands and
helices are shown in black in regions modeled based on the templates, while regions folded de novo are shown in grey. Mutational data for Cfr are
annotated above the sequence for essential (ﬁlled inverted triangles), conditional (asterisks), and non-essential (ampersand) positions.
Nucleic Acids Research,2010, Vol.38, No. 5 1655alignment of the 731 related sequences. The tree shown in
Figure 2 conﬁrms the existence of two main subfamilies
comprising Cfr and RlmN homologs, respectively, and
suggests the presence of an additional small subfamily
with enzymes of unknown function. The RlmN branch
comprises members from most bacterial taxons and its
topology generally agrees with the universally accepted
taxonomy of bacteria (32). In contrast, the Cfr branch
contains representatives from only a few taxons:
eukaryotic (green plants, alveolates, Choanoﬂagellida)
and bacterial (Chlamydiae/Verrucomicrobia group,
Planctomycetes and Staphylococci). In the Cfr branch,
the relationships of the proteins completely disagree with
the taxonomy of the host organisms (e.g. proteins from
the same taxon are found on diﬀerent sub-branches with
members from other diﬀerent taxons). The data suggest
that vertical transfer has governed the evolution of the
RlmN while Cfr has evolved in a horizontal manner.
Thus, it is likely that RlmN represents the ancestral
form, while members of the Cfr family are most likely
products of duplication(s) and horizontal gene transfer(s).
Cfr/RlmN-like proteins are only present in Eukaryota
that contain plastids (plants and choanoﬂagellates) or
whose ancestor is predicted to contain plastids
(alveolates). They are also absent from Archaea with the
exception of Nitrosopumilus maritimus. This suggests
that the Cfr/RlmN family has a bacterial origin and
other taxons acquired their members by horizontal gene
transfer(s). Plants contain up to three members of the
Cfr/RlmN family (e.g. AT2G39670, AT1G60230 and
AT3G19630 in Arabidopsis thaliana), which appear to be
phylogenetically associated with Cyanobacteria and
Proteobacteria in the RlmN branch, and with Alveolata
in the Cfr branch, respectively. Predictions of subcellular
localizations with the WoLFPSORT method (33) failed to
indicate any preference associated with any of the tree
lineages (e.g. diﬀerent members of each lineage are pre-
dicted to be targeted to diﬀerent compartments). None-
theless, the distribution of bacterial and plant members
suggests a scenario in which most of bacterial members
of the RlmN lineage are orthologs, direct (vertical) descen-
dants of the ancestor of the family. The cyanobacterial
RlmN has presumably been transferred to plants via the
chloroplast endosymbiont. Additional horizontal transfers
contributed to the emergence of these RlmN family
members, whose position on the tree clearly disagrees
with the organismal phylogeny (e.g. a crenarchaeal
RlmN ortholog on a branch with plants and Cyano-
bacteria or one of the plant members on the branch
comprising mostly Deltaproteobacteria). We speculate
that the ancestral Cfr paralog has been created by
gene duplication in a plant cell, from which it has been
transferred to alveolates and bacteria, including
Firmicutes (clostridia, bacilli and staphylococci). This
implies that the ability of Cfr to introduce the m
8A
modiﬁcation is a novel feature. It will be interesting to
determine whether its plant homologs also share this
activity, which might provide clues as to the physiological
role of Cfr and its function beyond antibiotic resistance
in bacteria.
Generation and validation of a structural model of Cfr
As a starting point for a structural model of Cfr, a protein
fold-recognition (FR) analysis of the Cfr sequence was
performed. FR methods attempt to identify the most
appropriate modeling templates for a query sequence
and report a series of alignments to proteins of known
structure. The analysis conﬁrmed with a high reliability
(Pcons score 2.64, with values >1 indicating a conﬁdent
prediction) that Cfr contains a radical-SAM domain in the
central part of the sequence (residues 103–312). Most FR
methods included in the MetaServer consistently reported
the structure of the radical-SAM enzyme molybdenum
cofactor biosynthesis protein A (MoaA; PDB code:
1tv8) as the potentially best template for modeling of the
central domain in Cfr (top six matches to MoaA, with
Pcons scores 2.09–2.64). Despite the unanimous identiﬁ-
cation of the radical-SAM domain in the central part of
the Cfr sequence, FR alignments by diﬀerent methods
showed diﬀerences, suggesting that modeling of the Cfr
structure may be a challenge. In addition, a drawback of
a template-based modeling procedure is the inability to
model ‘structurally variable regions’ (SVRs, e.g. large
insertions, terminal extensions, etc.) that have no counter-
part in any of the templates. The Cfr sequence contains
two such regions, the N-terminal region (residues 1–102)
and the C-terminal region (residues 313–349). The FR
analyses of the terminal regions of Cfr showed no statis-
tically signiﬁcant similarity to any structurally char-
acterized template and therefore had to be modeled
de novo.
A model of the central domain was constructed using
the ‘FRankenstein’s Monster’ protocol designed to
overcome the lack of consensus in the FR alignments
(16). As expected from comparative modeling, the
central domain of Cfr revealed features of its templates,
namely an a/b domain with a topology of an incomplete
TIM-barrel that is characteristic for radical-SAM
enzymes (34). The variable N- and C-termini were
modeled de novo using ROSETTA and added to the
homology-modeled core. Interestingly, the model of the
N-terminal region shows an extension of the b-sheet in
the radical-SAM domain and an additional helical
domain, with a topology similar to HTH proteins, in par-
ticular the ‘winged helix’ (wH) superfamily (35). Thus, the
N-terminal region is likely to constitute an independent
domain, and it will be referred to as the N-terminal
domain (NTD). The C-terminal region folded to form
an extension of the other edge of the b-sheet in the
radical-SAM domain, in the form of a Rossmann-like
a/b/a unit, and does not appear to form an independent
domain. The ﬁnal model was obtained by optimization of
packing with REFINER and is presented in Figure 3.
The prediction of the potential deviation of the ﬁnal
model, comprised of both the homology-modeled core
and de novo folded termini, yields good scores with
MQAP methods. The program PROQ predicted an
LGscore of 4.163, which indicates a ‘very good model’,
while MetaMQAP predicted that the whole model
exhibits a root mean square deviation from the true struc-
ture on the order of 2.4A ˚ , and a predicted GDT_TS score
1656 Nucleic Acids Research, 2010,Vol.38, No. 5Figure 2. Phylogenetic tree of the Cfr/RlmN family. Branches comprising multiple sequences from the same taxon have been collapsed and are
illustrated as triangles marked by the taxon name. Individual sequences are labeled by six-letter abbreviations as described in Figure 1. Bootstrap
values are shown for nodes with support of >50%.
Nucleic Acids Research,2010, Vol.38, No. 5 1657of 65.8. These results suggest that our model of Cfr
is suﬃciently reliable as a framework to interpret
sequence–function relationships in the Cfr family, at
least on the level of amino acid residues. The predicted
accuracy of the model is, however, too low for analysis
of atomic-level details, docking of ligands by high-
resolution ab initio methods, and inferring the mechanism
of enzymatic reaction by quantum-chemistry methods.
Furthermore, the model is probably outside the native
energy minimum, and energy minimization is thus not
expected to improve its quality.
Prediction of protein–ligand interactions
The binding mode of the 4Fe–4S cluster and the SAM
molecule is conserved among all radical-SAM enzymes
(34), suggesting that a protein–ligand complex structure
can be constructed by using information from homolo-
gous proteins. As we consider Cfr to be a radical-SAM
MTase, we infer that it needs the 4Fe–4S cluster and the
radical-SAM ligands for a radical reaction on C8 in
adenosine and an additional SAM as methyl donor. We
thus decided to illustrate the potential protein–ligand
interactions in Cfr by copying the Fe–S complex and
one SAM molecule, hereafter referred to as SAM1, from
the molybdenum cofactor biosynthesis protein A complex
structure. As MoaA uses only one SAM molecule, the
additional SAM molecule (the putative methyl group
donor), has been included in our model of Cfr by
analogy to the SAM2 molecule in another radical-SAM
enzyme, the coproporphyrinogen III oxidase (HemN;
PDB code: 1olt). The suggested complex structure of Cfr
with the ligands is illustrated in Figure 3. Thus, we infer
that residues from the loop comprising the CX3CX2C
motif and from the third and fourth b-strands coordinate
the 4Fe–4S cluster and SAM1, respectively; while residues
from the two b-strands that precede the catalytic triad of
cysteines and from the last C-terminal helix coordinate the
Figure 3. Structural models of the Cfr methyltransferase. The same orientation is shown in all panels, with the N-terminus on the right and
C-terminus on the left side. The Fe–S cluster and SAM molecules are colored according to the atom type. The coordinates are available from
ftp://genesilico.pl/iamb/models/RadicalSAM/Cfr/. (A) The protein backbone is shown in the ribbon representation. Functionally important residues
assayed by mutagenesis are labeled and shown in the space-ﬁlled representation and colored according to the eﬀect of mutagenesis: red for complete
loss of activity, orange for very low activity or yellow for reduced activity. The non-essential residue C110 is indicated in green. (B) The Cfr model
shown in the ribbon representation, colored according to the predicted error of the model (i.e. the predicted local deviation from the real structure),
as calculated by MetaMQAP. Blue indicates low predicted deviation of Ca atoms down to 0A ˚ , red indicates unreliable regions with deviation >5A ˚ ,
green to orange indicate intermediate values. (C) The model in surface representation, colored according to the distribution of electrostatic potential,
from red (negatively charged) to blue (positively charged). (D) The model in the surface representation, colored according to the sequence conser-
vation in the Cfr/RlmN family, from deep blue (invariant), to light blue (conserved), to yellow/red (highly variable).
1658 Nucleic Acids Research, 2010,Vol.38, No. 5SAM2 molecule. We must emphasize that the position and
orientation of the SAM2 molecule is probably the most
speculative aspect of the presented model.
Calculation of the electrostatic potential for the Cfr
model (illustrated in Figure 3C) reveals that the surface
of the radical-SAM domain is mostly negatively charged,
while the NTD exhibits a positively charged surface.
Mapping of the sequence alignment onto the protein
structure (Figure 3D) shows a concentration of conserved
residues both in the radical-SAM domain and to a limited
extent also in the NTD, suggesting that both domains are
highly relevant for the enzyme function. We hypothesize
that the NTD facilitates speciﬁc binding to the negatively
charged RNA substrate.
Mutagenesis of the Cfr MTase and the eﬀect on
methylation activity
Mutations in Cfr were introduced in the cfr gene placed
after the inducible lac promoter and with an N-terminal
histidine tag. Each mutation consisted of a single amino
acid residue changed to alanine. A few mutations (R25A,
Q28A, C338A) have been introduced into the termini of
Cfr to determine whether the ends are important for Cfr
function. Other mutations have been introduced at amino
acids placed at the proposed functional sites for binding of
a 4Fe–4S cluster (C112A, C116A, C119A) and two mole-
cules of SAM (SAM1: F118A, S189A, S212A, H214A and
SAM2: E91A, C105A). The control mutation C110A was
introduced at a position that is conserved in the Cfr/RlmN
family, but is neither conserved among radical-SAM
enzymes nor makes interactions with ligands in our
model and is presumably unimportant.
The activity of the diﬀerent Cfr mutants was assayed by
antibiotic susceptibility testing of a hypersensitive E. coli
strain (AS19) harboring plasmids expressing the mutant
Cfr proteins. The hypersensitive strain facilitates the
detection of moderate MIC changes in the Gram-
negative bacterium E. coli, which is intrinsically resistant
to many antibiotics. As expression of wild-type Cfr
confers a PhLOPSA resistance phenotype (3), the antibi-
otics ﬂorfenicol and tiamulin that represent two of the ﬁve
groups of antibiotics related to this phenotype were
chosen for assaying the eﬀect of the mutations. MICs
have been determined for strains expressing wild-type
and mutant Cfr proteins and the results are presented in
Table 1. In addition, various controls without plasmid and
with plasmids not containing the cfr gene were assayed to
assure that the observed eﬀects can be directly attributed
to Cfr expression. All the mutations introduced at poten-
tial functional sites lowered the MIC values signiﬁcantly
and thus aﬀect Cfr activity. The mutations E91A, C105A,
C112A, C116A, C119A, F118A, S212A and C338A elim-
inate the resistance to both ﬂorfenicol and tiamulin,
whereas Q28A and S189A lower the resistance consider-
ably and R25A and and H214A yield moderate decreases
in MIC values. The C110A control mutation does not
aﬀect Cfr activity as the MIC values obtained for this
mutant are indistinguishable from those of the wild-type
Cfr protein.
To further substantiate that the observed MICs are a
direct consequence of Cfr activity or lack thereof, position
A2503 was assayed for methylation. It has been observed
previously that the Cfr-mediated m
8A2503 methylation
causes a partial reverse transcriptase stop in primer exten-
sion assays (2,3,6). Cfr also represses the YgdE-mediated
ribose methylation (36) of C2498 by lowering the intensity
of the primer extension stop from this modiﬁcation (2).
Primer extension analysis was performed on total RNA
isolated from strains expressing the mutant Cfr proteins.
The E. coli JW2501-1 strain, that does not contain the
RlmN MTase that normally mediates the m
2A2503 mod-
iﬁcation, was used as the host for plasmids expressing the
mutated Cfr proteins and isolation of total RNA. This
was done to avoid the weak primer extension stop from
the m
2A2503 methylation that overlaps the Cfr-mediated
m
8A2503 stop and would therefore interfere with assess-
ment of the activity of the mutated Cfr proteins. The
primer extension analysis is presented in Figure 4A.
The C110A control mutation that does not aﬀect MIC
values mediates the appearance of a clear strong band at
position 2503 by primer extension analysis, indicating a
m
8A2503 methylation similar to the wild-type enzyme.
For most of the mutants that exhibit changes in MICs
relative to wild-type Cfr, analysis of 23S rRNA results
in either a weak band or no band at position A2503.
This is consistent with an inactivated or partially
inactivated Cfr and the decreased MIC values observed
for these mutants. The C112A, C116A and C119A muta-
tions of the CX3CX2C motif at the presumed 4Fe–4S
cluster binding site do not yield any primer extension
stop at position A2503, in accordance with a complete
inactivation of the Cfr RNA modiﬁcation activity. The
same pattern is seen for the C338A mutation, suggesting
a vital importance of this residue. Mutations in the
Table 1. Antibiotic susceptibilities of E. coli AS19 strains with
plasmid-encoded cfr genes
Plasmid cfr gene Site of Cfr
mutation
FFC MIC
(mg/ml)
TIA MIC
(mg/ml)
No plasmid   n.a. 1–2 2
pBluescript (-Cfr)   n.a. 1 1
pLJ102 (-Cfr)   n.a. 1 2
pCfrHisR25A + NTD 16 8
pCfrHisQ28A + NTD 2–4 4
pCfrHisC338A + C-terminus 1 2
pCfrHisC112A + 4Fe-4S 1–2 2
pCfrHisC116A + 4Fe-4S 1 2
pCfrHisC119A + 4Fe-4S 1 2
pCfrHisF118A + SAM1 1–2 1–2
pCfrHisS189A + SAM1 2–4 4
pCfrHisS212A + SAM1 2 2
pCfrHisH214A + SAM1 16–32 32
pCfrHisE91A + SAM2 2 2
pCfrHisC105A + SAM2 1 2
pCfrHisC110A + Non-conserved 32 >128
pCfrHis + None 32 >128
pBglII (+Cfr) + None 16–32 128
FFC, ﬂorfenicol; TIA, tiamulin; MIC, minimal inhibitory concentra-
tion; n.a., not applicable; NTD, N-terminal domain. The 4Fe–4S,
SAM1, and SAM2 sites are explained in the Results section.
Nucleic Acids Research,2010, Vol.38, No. 5 1659predicted SAM1-binding site give rise to a very faint band
(F118A and S212A) or a weak band (S189A and H214A),
in accordance with nearly background and reduced
activities, respectively, also observed with the MIC
values. R25A and Q28A mutations in the NTD mediate
a band of intermediate intensity, again in good qualitative
agreement with the observed intermediate MIC values.
Surprisingly, the E91A and C105A mutations in the
predicted SAM2-binding site produce a clear band at the
2503 position despite a sensitive phenotype indicating
the absence of methylated and thus antibiotic-resistant
ribosomes. A 23S rRNA fragment was isolated from
mutant C105A total RNA and MS analysis was per-
formed as previously described for the identiﬁcation of
Cfr as a MTase (2). The MALDI-TOF MS analysis
showed no evidence of methylation at position A2503
(data not shown). Thus, the MS data showing no
methylation is in agreement with the MICs showing no
resistance. We then hypothesized that the band could
originate from a fraction of 23S RNA molecules that
interacted in an inappropriate way with the mutated Cfr,
and as a consequence were not incorporated into func-
tional ribosomes. This was investigated by isolating
ribosomes from mutant and control strains and perform-
ing primer extension analysis on 23S RNA (shown in
Figure 4B). The relative strength of the primer extension
stops at A2503 in 23S RNA from mutant E91A is only
decreased marginally in the ribosomal RNA samples
compared to the total RNA samples. The pattern for
mutant C105A is diﬀerent as the stop is almost absent in
RNA from 70S ribosomes. The sucrose gradient from this
mutant showed an unusually large 50S fraction and there-
fore RNA from this peak was also investigated by primer
extension (rightmost lane in Figure 4B) and shows a
strong stop at the A2503 position. There is thus a selection
against the Cfr-aﬀected RNA in puriﬁed 70S while this
RNA is present in the 50S fraction. Taken together, the
data suggest that Cfr mutants E91A and C105A carry out
a reaction that results in a primer extension stop, but
whose product is not methylated and does not lead to
the formation of antibiotic-resistant ribosomes. One pos-
sibility is that a portion of 23S rRNA is cleaved or abasic
at this position. At present the primer extension band is a
mystery that is beyond the scope of the current
investigation.
DISCUSSION
Cfr as the founding member of Class VII MTases and
its relation to othes MTases
The SAM-dependent MTases have been grouped into ﬁve
classes that are unrelated in sequence, structure,
phylogenetic origin and in the details of protein–SAM
interactions (37). A sixth class is represented by a trans-
membrane protein, isoprenylcysteine carboxyl MTase
(ICMTase) (38). A number of other enzyme superfamilies
utilize SAM as a cofactor or cosubstrate in various reac-
tions, other than the transfer of the methyl group (39).
Among them, the radical-SAM superfamily belongs to
the most diverse groups of enzymes, as its members have
been found to catalyze reactions such as unusual
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Figure 4. Primer extension analysis of reverse transcriptase stops on 23S RNA from E. coli strains harbouring various plasmids expressing Cfr and
mutated Cfr or control plasmids. The numbers above the gel correspond to the mutated amino acids (compare with Table 1 for further information).
The region shown is limited to the nucleotides ﬂanking A2503 that is methylated by Cfr and C2498 where Cfr inhibits methylation. Lanes marked C,
U, A and G refer to dideoxysequencing reactions. Reverse transcriptase stops one nucleotide before the corresponding nucleotide in the sequencing
lanes. Panel (A) shows primer extension on total RNA from JW2501-1 strains harboring the indicated plasmids. Panel (B) shows primer extension on
rRNA from isolated 70S ribosomes (r) compared to analysis of total RNA (t) from JW2501-1 strains harboring pCfrHis or mutated plasmids. The
rightmost lane marked ‘x’ shows primer extension analysis of 23S RNA isolated from 50S subunits from mutant C105A (+IPTG). The positions of
bands representing A2503 and C2498 are indicated by arrows on the right and horizontal bars on the left. The numbers above the gels refer to the
amino acids that have been mutagenized.
1660 Nucleic Acids Research, 2010,Vol.38, No. 5methylations, isomerization, sulfur insertion, ring forma-
tion, anaerobic oxidation and protein-radical formation
(9). This diversity of reactions is reﬂected in the divergence
of sequences and structures among the radical-SAM
enzymes compared to other SAM-dependent MTase
superfamilies.
There are only few radical-SAM enzymes that catalyze
methylation or related reactions. Cfr has been the ﬁrst
experimentally characterized bona ﬁde MTase among all
radical-SAM enzymes (10), and hence we designate it as
the founding member of Class VII SAM-dependent
MTases. The radical-SAM enzyme family includes two
experimentally characterized MTases BchQ and BchR
that are involved in modiﬁcation of bacteriochlor-
ophyllide c at C-8
2 and C-12
1 atoms (40). The MTase
CloN6 also belongs to the radical-SAM superfamily and
is involved in methylation of the aminocoumarin antibi-
otic clorobiocin, but this enzyme is believed to use
methylcobalamin rather than SAM as the methyl group
donor (41). Thus, these enzymes perform reactions that
are very diﬀerent from Cfr methylation and are
probably not useful for inferring the mechanism of Cfr
methylation.
Other radical-SAM enzymes that target the
translational apparatus catalyze thiomethylation reac-
tions. The MiaB enzyme catalyzes thiomethylation of
the C-2 atom of N
6-(isopentenyl) adenosine (i
6A)-37 in
tRNA (42) and the related RimO enzyme adds a
thiomethyl group to the Cb atom of amino acid residue
D88 of ribosomal protein S12 (43). The remote homology
of Cfr/RlmN and MiaB is intriguing, given the fact that all
three enzymes act on adenosine in RNA and that RlmN
and MiaB modify the same C2 atom. MiaB has been
postulated to use two molecules of SAM, where SAM1
generates the radical and SAM2 acts as methyl donor
(42). Although it was originally proposed that MiaB
inserts sulfur from the ﬁrst SAM molecule, it has
recently been shown that this enzyme contains an addi-
tional Fe–S cluster, and it has been proposed that this
second cluster acts as a sacriﬁcial S-donor (44). We
suggest that Cfr uses two SAM molecules like MiaB,
where SAM1 is used to generate a highly reactive
reaction intermediate, essentially as in all radical-SAM
enzymes, while the SAM2 molecule is used as a methyl
group donor. The methyl transfer step for Cfr and
RlmN might thus be related to the ﬁnal step of the reac-
tions catalyzed by MiaB and RimO.
Although the structures of RlmN and MiaB are not
known, we speculate that they bind the target adenosine
residue in a similar manner and use a similar reaction
mechanism. It is interesting that Cfr methylates the C-8
atom of adenosine despite its close relationship to RlmN,
however Cfr has been found to exhibit latent m
2A MTase
activity (6). Based on our phylogenetic analysis we suggest
that the C-8 methylation activity is a new invention of Cfr,
and that the ancestor of RlmN and Cfr was a m
2A MTase.
It is noteworthy that so far no MTases from the more
ubiquitous RFM (45) or SPOUT (46) superfamilies have
been found to carry out m
2Ao rm
8A methylation, which
probably reﬂects the challenging chemistry of modiﬁca-
tion of endocyclic carbon atoms.
Structure-based interpretation of experimental data
Like all theoretical models of protein structure, our model
of Cfr is obviously less accurate than typical X-ray crystal
and NMR structures but no experimental model of Cfr or
any closely related protein is currently available. From the
theoretical evaluation by MQAP methods, we consider the
current theoretical model to be suﬃciently accurate to
guide new experimental analyses at the level of individual
amino acid residues (e.g. site-directed mutagenesis). For
initial experimental testing, we selected a set of residues
with functional predictions ranging from obvious (e.g. the
Cys motif common to all radical-SAM enzymes) to very
non-trivial (residues located in elements that were diﬃcult
to model or had no correspondence in other radical-SAM
enzymes). The mutagenesis analysis shows that all amino
acid residues chosen due to their potential importance
actually inﬂuence Cfr activity considerably and about
half of them completely destroyed the methylation
activity (Table 1), implying that they are of high func-
tional importance and presumably positioned in func-
tional sites. As expected, alanine mutagenesis of the
invariant residues C112, C116, C119, forming the
well-conserved Fe–S cluster-binding motif, completely
abolished Cfr function. Interestingly, alanine substitutions
of the invariant residue C338 in a Cfr-speciﬁc sequence
motif ‘ACGQL’ in the C-terminal helix also caused total
inactivation of the enzyme. In our model, this residue is
buried in the structure and therefore the eﬀect of the
mutation may be due to destabilization of the protein.
However, this part of the protein has been constructed
de novo, so its true conformation may be diﬀerent, and
this Cfr-speciﬁc motif could be involved in interactions
with the RNA substrate and/or ligands. The eﬀects of
mutations in the conserved SAM1-binding site are
almost as strong as for the invariant Cys residus, with
two mutants (F118A and S121A) showing barely detect-
able activity and two mutants with weak activity (S189A
and H214A). This is in agreement with the relative impor-
tance of predicted contacts in the enzyme. According to
our model, F118 forms a stacking interaction with the
adenosine moiety of SAM1, S212 may interact with the
30 hydroxyl group of the ribose moiety, while S189 may
coordinate the carboxyl group of the methionine moiety.
H214 is more distant from SAM1, and may be involved in
its long-range coordination. The semi-conserved residues
R25 and Q28 are located in the NTD in a part of the
molecule unique to the Cfr/RlmN family and predicted
to be involved in binding of the substrate RNA. Sub-
stitutions at these two positions show only partial loss of
activity. Such an eﬀect is analogous to the eﬀect of
mutating RNA-binding residues in other RNA MTases,
including ErmC0 (47) and Sgm (48). Although not direct
evidence, this result is consistent with our prediction of the
NTD as an interface for RNA binding by Cfr.
The most interesting mutagenesis eﬀects are observed
with residues E91 and C105 located in two b-strands pre-
ceding the CX3CX2C motif, and predicted to be involved
in binding of the SAM2 molecule, the suggested methyl
group donor. Accordingly, mutants with alanine substitu-
tions at these positions may show aberrant or no binding
Nucleic Acids Research,2010, Vol.38, No. 5 1661of SAM2. In agreement with this prediction, the antibiotic
susceptibility of such mutants is as low as those with
mutations in the SAM1-binding site. Nonetheless, these
mutant enzymes are carrying out some unknown transfor-
mation of the substrate, manifested as a primer extension
stop in the product RNA that does not lead to the forma-
tion of antibiotic-resistant ribosomes. It could be that
E91A and C105A mutants are still capable of binding
SAM1 and can initiate the reaction, but cannot ﬁnish it
without the properly bound SAM2 methyl group donor.
This may result in release of a substrate with some form of
damage or modiﬁcation that is manifested as a primer
extension stop without leading to antibiotic resistance.
These mutants emphasize the functional versatility of
radical-SAM enzymes and may be regarded as ‘engi-
neered’ variants of Cfr with altered reaction mechanisms.
Investigation of their activity will be the subject of future
studies.
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